Greater China
Chinese AI diagnosis player Shukun raises $108m
Shukun, a Chinese developer of artificial intelligence (AI) technology used in medical imaging diagnosis, has raised RMB700 million ($108 million) from Goldman Sachs, Primavera Capital Group, Sequoia Capital China, Marathon Venture Partners, and Sage...
Sofina, CDH wealth platform lead round for China's Petkit
Petkit, a Chinese manufacturer of smart devices for pets such as water and food dispensers, has raised $50 million in a Series D round of funding led by Sofina and CDH Investments' wealth management platform.
Guotai leads $66m Series B extension for China's Innovusion
Innovusion, a Chinese developer of LiDAR technology used in autonomous driving, has raised $66 million in an extended Series B round led by the private equity investment arm of Guotai Junan International.
Boyu, Janchor back China medical finance start-up
MediTrust Health, China-based healthcare payments and insurance platform, has raised RMB2 billion ($309 million) in Series C funding led by Boyu Capital and Janchor Partners.
Taiwan's AppWorks raises $150m for Fund III
AppWorks, a Taiwan-based venture capital firm and accelerator that also covers Southeast Asia, has closed its third fund at the hard cap of $150 million, taking its total assets under management to $212 million.
Vision Fund pulls back from China amid regulatory uncertainty
SoftBank Vision Fund is taking a “wait and see” approach to China, holding back on new investments in the country until the full ramifications of regulatory action in the technology sector are known.
China's Miaoshou Doctor raises $231m Series F
Beijing Yuanxin Technology, operator of China-based online healthcare services platform Miaoshou Doctor, has raised RMB1.5 billion ($231 million) in Series F funding featuring Sequoia Capital China.
China education: Opportunity erased?
Private equity investors have pumped billions of dollars into Chinese online education platforms, notably in the K-12 space. A regulatory crackdown has left them wondering how they can get their money back
CPE leads $150m Series B for China CDMO
Joinn Biologics, a China-based contract development and manufacturing organization (CDMO), has raised $150 million in Series B funding led by CPE.
China cancer screening specialist raises $99m
China Merchants Capital has led a $99.5 million funding round for Berry Oncology Corporation, an early cancer screening spin-out from China-based genetic testing specialist Berry Genomics.
Primavera pursues China online education take-private
Primavera Capital Group has submitted a $33.3 million take-private bid for Liulishuo, a China-based operator of an English language learning app. The company's stock has struggled following a recent crackdown on online education platforms in China.
GLP, Sequoia commit $800m to China's Harvest Capital
Harvest Capital, a China-based private equity firm that focuses on the consumer sector, has received a strategic investment of nearly $800 million from GLP – a regional logistics platform and investment manager- and Sequoia Capital China.
China AI drug developer BioMap raises $100m
GGV Capital has led a $100 million Series A round for BioMap, a China-based biological computing platform. It marks the first time the company has sought external funding.
Coller spins out credit fund interests from Ping An subsidiary
A Coller Capital-led consortium has acquired interests in four global credit funds – worth a combined $680 million – from China Ping An Insurance’s overseas investment platform.
China autonomous driving start-up Inceptio raises $270m
Inceptio, a Chinese autonomous driving technology provider focusing on line-haul trucking, has raised a $270 million Series B round led by JD Logistics, Meituan, and PAG.
Profile: E15 VC's Philip Liang
From social networking for dogs to surgical robotics, Philip Liang’s career as an entrepreneur and investor has been rich and varied. He welcomes the barrage of ideas filling his inbox at Hong Kong-based E15 VC
China's Vitalbridge reaches $200m first close on Fund II
Vitalbridge Capital, a China-based venture capital firm that spun out from Trustbridge Partners, has achieved a first close of $200 million on its second US dollar-denominated fund.
CMC invests $93m in China liquor brand
Forty-Nine Union, a Chinese liquor brand, has raised a Series B round of RMB600 million ($93 million) from CMC Capital Group. There were no other participants in the round.
PAG raises $525m for second China growth fund
PAG has closed its second growth fund, which makes middle-market investments – predominantly in China – that fall below the minimum check size for its pan-Asian vehicle at $525 million.
Navis raises $900m for Fund VIII, closes Fund VI continuation
Navis Capital Partners has closed its eighth regional fund at $900 million, while also securing $450 million for a continuation vehicle that features five companies from its sixth fund.
Sequoia China leads $100m Series B for Bota Biosciences
Sequoia Capital China had led a $100 million Series B round for Bota Biosciences, a China-based biotech company that has developed a next-generation platform for manufacturing high-performing industrial compounds.
Airwallex founders launch VC fund
The founders of Hong Kong-headquartered financial technology provider Airwallex, which has received $500 million in VC funding, have launched their own venture capital fund.
GIC invests $240m in Arctic Green Energy
Singapore sovereign wealth fund GIC has committed $240 million to Arctic Green Energy (AGE), an Iceland-based geothermal energy developer that has already received substantial Chinese backing.
China automotive chip maker Semidrive raises $154m
Semidrive Technology, a specialist semiconductor manufacturer for the automotive industry, has raised RMB1 billion ($154 million) in Series B funding led by Pro Capital and V Fund.